Post-Operative Pain - Pipeline Review, H2 2015

Published: October 2015
No. of Pages: 169
   

Global Markets Direct’s, ‘Post-Operative Pain - Pipeline Review, H2 2015’, provides an overview of the Post-Operative Pain’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Post-Operative Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Post-Operative Pain and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Post-Operative Pain
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Post-Operative Pain and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Post-Operative Pain products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Post-Operative Pain pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products

Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Post-Operative Pain
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Post-Operative Pain pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Post-Operative Pain - Pipeline Review, H2 2015

Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Post-Operative Pain Overview 8
Therapeutics Development 9
Pipeline Products for Post-Operative Pain - Overview 9
Pipeline Products for Post-Operative Pain - Comparative Analysis 10
Post-Operative Pain - Therapeutics under Development by Companies 11
Post-Operative Pain - Pipeline Products Glance 13
Late Stage Products 13
Clinical Stage Products 14
Early Stage Products 15
Unknown Stage Products 16
Post-Operative Pain - Products under Development by Companies 17
Post-Operative Pain - Companies Involved in Therapeutics Development 20
A. Menarini Industrie Farmaceutiche Riunite Srl 20
AcelRx Pharmaceuticals, Inc. 21
Adynxx, Inc. 22
Amorsa Therapeutics Inc. 23
AngioChem Inc. 24
AskAt Inc. 25
Boehringer Ingelheim GmbH 26
Cara Therapeutics, Inc. 27
Chong Kun Dang Pharmaceutical Corp. 28
Colby Pharmaceutical Company 29
Cytogel Pharma, LLC 30
DURECT Corporation 31
Echo Pharmaceuticals B.V. 32
Flexion Therapeutics, Inc. 33
Fujimoto Pharmaceutical Corporation 34
Galleon Pharmaceuticals 35
Grunenthal GmbH 36
GW Pharmaceuticals Plc 37
Heron Therapeutics, Inc. 38
Immupharma Plc 39
Laboratorios Del Dr. Esteve S.A. 40
Lipocure Ltd. 41
Medtronic plc 42
Navigen Pharmaceuticals, Inc. 43
Orbis Biosciences, Inc. 44
Orion Oyj 45
PainReform Ltd. 46
Pharmazz, Inc. 47
PhytoHealth Corporation 48
Recro Pharma, Inc. 49
Takeda Pharmaceutical Company Limited 50
Thar Pharmaceuticals, Inc. 51
Trevena, Inc. 52
Post-Operative Pain - Therapeutics Assessment 53
Assessment by Monotherapy Products 53
Assessment by Combination Products 54
Assessment by Target 55
Assessment by Mechanism of Action 58
Assessment by Route of Administration 61
Assessment by Molecule Type 63
Drug Profiles 65
(bupivacaine hydrochloride + meloxicam) - Drug Profile 65
(dexketoprofen + tramadol hydrochloride) - Drug Profile 66
AM-4 - Drug Profile 67
AMS-410 ER12 - Drug Profile 68
ANG-2002 - Drug Profile 69
ARX-04 - Drug Profile 70
AYX-1 - Drug Profile 72
BI-1026706 - Drug Profile 73
bupivacaine hydrochloride - Drug Profile 74
bupivacaine hydrochloride - Drug Profile 75
bupivacaine hydrochloride SR - Drug Profile 77
CKD-943 - Drug Profile 79
CMX-020 - Drug Profile 80
CPC-123 - Drug Profile 81
CR-845 - Drug Profile 82
Cyt-1010 - Drug Profile 85
dexmedetomidine hydrochloride - Drug Profile 87
dronabinol - Drug Profile 89
E-52862 - Drug Profile 91
ECP-1014 - Drug Profile 93
fadolmidine hydrochloride - Drug Profile 94
FX-007 - Drug Profile 96
GAL-044 - Drug Profile 97
grapiprant - Drug Profile 98
IPP-102199 - Drug Profile 100
ketamine hydrochloride - Drug Profile 101
ketamine hydrochloride ER - Drug Profile 103
MDT-10013 - Drug Profile 104
meloxicam - Drug Profile 105
nabiximols - Drug Profile 106
nalbuphine hydrochloride - Drug Profile 109
oliceridine - Drug Profile 110
Peptide for Post Operative Pain - Drug Profile 111
PMZ-2010 - Drug Profile 112
RBM-004 - Drug Profile 114
ropivacaine - Drug Profile 115
ropivacaine ER - Drug Profile 116
sufentanil citrate - Drug Profile 117
T-109 - Drug Profile 120
tapentadol hydrochloride - Drug Profile 121
tramadol hydrochloride - Drug Profile 123
tramadol hydrochloride - Drug Profile 124
URB-937 - Drug Profile 125
VVZ-149 - Drug Profile 126
Post-Operative Pain - Recent Pipeline Updates 127
Post-Operative Pain - Dormant Projects 155
Post-Operative Pain - Discontinued Products 157
Post-Operative Pain - Product Development Milestones 158
Featured News & Press Releases 158
Appendix 165
Methodology 165
Coverage 165
Secondary Research 165
Primary Research 165
Expert Panel Validation 165
Contact Us 165
Disclaimer 166

List of Tables

Number of Products under Development for Post-Operative Pain, H2 2015 12
Number of Products under Development for Post-Operative Pain - Comparative Analysis, H2 2015 13
Number of Products under Development by Companies, H2 2015 14
Comparative Analysis by Late Stage Development, H2 2015 16
Comparative Analysis by Clinical Stage Development, H2 2015 17
Comparative Analysis by Early Stage Development, H2 2015 18
Comparative Analysis by Unknown Stage Development, H2 2015 19
Products under Development by Companies, H2 2015 20
Products under Development by Companies, H2 2015 (Contd..1) 21
Products under Development by Companies, H2 2015 (Contd..2) 22
Post-Operative Pain - Pipeline by A. Menarini Industrie Farmaceutiche Riunite Srl, H2 2015 23
Post-Operative Pain - Pipeline by AcelRx Pharmaceuticals, Inc., H2 2015 24
Post-Operative Pain - Pipeline by Adynxx, Inc., H2 2015 25
Post-Operative Pain - Pipeline by Amorsa Therapeutics Inc., H2 2015 26
Post-Operative Pain - Pipeline by AngioChem Inc., H2 2015 27
Post-Operative Pain - Pipeline by AskAt Inc., H2 2015 28
Post-Operative Pain - Pipeline by Boehringer Ingelheim GmbH, H2 2015 29
Post-Operative Pain - Pipeline by Cara Therapeutics, Inc., H2 2015 30
Post-Operative Pain - Pipeline by Chong Kun Dang Pharmaceutical Corp., H2 2015 31
Post-Operative Pain - Pipeline by Colby Pharmaceutical Company, H2 2015 32
Post-Operative Pain - Pipeline by Cytogel Pharma, LLC, H2 2015 33
Post-Operative Pain - Pipeline by DURECT Corporation, H2 2015 34
Post-Operative Pain - Pipeline by Echo Pharmaceuticals B.V., H2 2015 35
Post-Operative Pain - Pipeline by Flexion Therapeutics, Inc., H2 2015 36
Post-Operative Pain - Pipeline by Fujimoto Pharmaceutical Corporation, H2 2015 37
Post-Operative Pain - Pipeline by Galleon Pharmaceuticals, H2 2015 38
Post-Operative Pain - Pipeline by Grunenthal GmbH, H2 2015 39
Post-Operative Pain - Pipeline by GW Pharmaceuticals Plc, H2 2015 40
Post-Operative Pain - Pipeline by Heron Therapeutics, Inc., H2 2015 41
Post-Operative Pain - Pipeline by Immupharma Plc, H2 2015 42
Post-Operative Pain - Pipeline by Laboratorios Del Dr. Esteve S.A., H2 2015 43
Post-Operative Pain - Pipeline by Lipocure Ltd., H2 2015 44
Post-Operative Pain - Pipeline by Medtronic plc, H2 2015 45
Post-Operative Pain - Pipeline by Navigen Pharmaceuticals, Inc., H2 2015 46
Post-Operative Pain - Pipeline by Orbis Biosciences, Inc., H2 2015 47
Post-Operative Pain - Pipeline by Orion Oyj, H2 2015 48
Post-Operative Pain - Pipeline by PainReform Ltd., H2 2015 49
Post-Operative Pain - Pipeline by Pharmazz, Inc., H2 2015 50
Post-Operative Pain - Pipeline by PhytoHealth Corporation, H2 2015 51
Post-Operative Pain - Pipeline by Recro Pharma, Inc., H2 2015 52
Post-Operative Pain - Pipeline by Takeda Pharmaceutical Company Limited, H2 2015 53
Post-Operative Pain - Pipeline by Thar Pharmaceuticals, Inc., H2 2015 54
Post-Operative Pain - Pipeline by Trevena, Inc., H2 2015 55
Assessment by Monotherapy Products, H2 2015 56
Assessment by Combination Products, H2 2015 57
Number of Products by Stage and Target, H2 2015 59
Number of Products by Stage and Mechanism of Action, H2 2015 62
Number of Products by Stage and Route of Administration, H2 2015 65
Number of Products by Stage and Molecule Type, H2 2015 67
Post-Operative Pain Therapeutics - Recent Pipeline Updates, H2 2015 130
Post-Operative Pain - Dormant Projects, H2 2015 158
Post-Operative Pain - Dormant Projects (Contd..1), H2 2015 159
Post-Operative Pain - Discontinued Products, H2 2015 160

List of Figures

Number of Products under Development for Post-Operative Pain, H2 2015 12
Number of Products under Development by Companies, H2 2015 14
Comparative Analysis by Late Stage Development, H2 2015 16
Comparative Analysis by Clinical Stage Development, H2 2015 17
Comparative Analysis by Early Stage Products, H2 2015 18
Assessment by Monotherapy Products, H2 2015 56
Assessment by Combination Products, H2 2015 57
Number of Products by Top 10 Targets, H2 2015 58
Number of Products by Stage and Top 10 Targets, H2 2015 58
Number of Products by Top 10 Mechanism of Actions, H2 2015 61
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015 61
Number of Products by Top 10 Routes of Administration, H2 2015 64
Number of Products by Stage and Top 10 Routes of Administration, H2 2015 64
Number of Products by Molecule Types, H2 2015 66
Number of Products by Stage and Molecule Types, H2 2015 66

Published By: Global Markets Direct
Product Code: Global Markets Direct13361


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we´┐Żll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Pharmaceuticals market as per your needs. Get the best of Pharmaceuticals research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest: